BioSpace News Archive

eTheRNA immunotherapies NV (‘eTheRNA’), an mRNA technology discovery and development company with a full platform of integrated capabilities, today announced that it will host a key opinion leader (KOL) webinar on mRNA-lipid nanoparticles (LNP) for cancer immunotherapy on Wednesday, March 2, 2022 at 10am ET / 3pm GMT / 4pm CET.

Agios Pharmaceuticals, Inc. announced the company is scheduled to present at the following March investor conferences.

Heska Corporation reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2021.

The global contact lens market is projected to witness considerable rise owing to rising prevalence of increased preference for contact lenses over prescribed eyeglasses for aesthetics purposes and rising cases of vision related problems like myopia.

Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures.

Rising of prevalence of cancer worldwide, technological advances in cancer therapies, and new product launches are among the key factors driving the global Radiotherapy market revenue growth.

Increasing geriatric population across the globe, rising incidence of chronic diseases, and growing healthcare expenditure are some key factors expected to drive Advanced Wound Care market revenue growth.

High adoption of blockchain technology in several hospitals and organizations, and favorable government initiatives are key factors expected to drive global market revenue growth.

Inventiva announced that its management team will host a webcast to present the Company’s full-year financial results for 2021 on Tuesday, March 8, 2022.

Rising prevalence of heart disease across the globe and increasing focus on development of personalized drugs & therapeutics are among the key factors driving the global Recurrent Atrial Fibrillation market revenue growth.